Privacy-preserving AI technique improves brain tumour detection
Intel Labs, in collaboration with the Perelman School of Medicine of the University of Pennsylvania’s (Penn Medicine), has completed a research study that used federated machine learning (ML) and artificial intelligence (AI) to identify malignant brain tumors.
This project, which is the largest medical federated-learning study ever conducted with a global dataset from 71 institutions on six continents and an unprecedented global dataset, showed that brain tumour detection could be improved by 33%.
Jason Martin, principal Engineer at Intel Labs, says: \”Federated Learning has enormous potential in many domains, especially within healthcare. Our research with Penn Medicine shows this.\” Its ability to protect sensitive data and information opens the door for further studies and collaborations, particularly in cases where datasets are otherwise inaccessible.